Radiation Oncology/Therapy: Page 32

Blue Earth touts positive prostate cancer trial results
By AuntMinnie.com staff writers
Blue Earth Therapeutics is highlighting clinical study results that suggest that its radiopharmaceutical labeled with lutetium-177 is effective for treating metastatic, castrate-resistant prostate cancer.
June 15, 2022
2020 07 15 23 29 3710 Cancer Cells Prostate 400
AI method reduces radiation exposure via virtual PET/CT images
By AuntMinnie.com staff writers
An artificial intelligence (AI) method can generate virtual attenuation-corrected PET/CT images -- which cuts patients' radiation exposure, according to research presented at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting.
June 14, 2022
2022 06 15 17 59 3671 2022 06 15 Low Res Snmmi2202 Abstract Ma 20220615171118
Fusion and Niowave ink $5M collaboration
By AuntMinnie.com staff writers
McMaster University spin-off company Fusion Pharmaceuticals and superconducting accelerator technology firm Niowave have inked a $5 million supply agreement for the development, production, and supply of actinium-225.
June 13, 2022
2020 07 20 23 40 0607 Handshake Meeting 400
Do nuclear medicine physicians need a new identity?
By Will Morton
VANCOUVER, BC - It's time to embrace a new identity in nuclear medicine -- namely, that of the "nuclear oncologist," said Dr. Richard Wahl in the president's address June 12 at the Society of Nuclear Medicine and Molecular Imaging annual meeting.
June 12, 2022
2021 06 15 20 50 5815 Wahl Richard 20210615203856
VA Ann Arbor expands use of ViewRay radiation therapy
By AuntMinnie.com staff writers
Radiation therapy developer ViewRay announced that the VA Ann Arbor Healthcare System (VAAAHS) is expanding to include advanced radiation therapy services through the MRIdian MRI-guided radiation system at the Lieutenant Colonel Charles S. Kettles VA Medical Center.
June 9, 2022
2019 09 17 16 42 0082 Viewray Astro 2019
Imaging Endpoints, ImaginAb expand partnership
By AuntMinnie.com staff writers
Contract research organization Imaging Endpoints and immuno-PET developer ImaginAb have inked a license agreement to supply clinical doses of ImaginAb's investigational zirconium-89 crefmirlimab berdoxam CD8 Immuno-PET agent to biopharma companies.
June 6, 2022
2016 08 24 09 43 13 537 Hands Shaking V3 400
NorthStar inks supply deal with Curie Therapeutics
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has inked a long-term supply agreement with Curie Therapeutics for NorthStar's actinium-225 therapeutic radioisotope.
June 6, 2022
2018 04 24 20 24 4264 Isotope 400
Older breast cancer patients may not need radiotherapy
By AuntMinnie.com staff writers
Women over the age of 55 with early-stage breast cancer may not need radiotherapy after breast-conserving surgery, according to research presented June 7 at the American Society of Clinical Oncology's annual meeting in Chicago.
June 6, 2022
2019 01 19 00 20 7950 Radiotherapy Breast Cancer 400
ViewRay MRI system used at Henry Ford Health
By AuntMinnie.com staff writers
ViewRay said that Detroit-based Henry Ford Health recently became the first center with the company's MRIdian radiation therapy technology to complete a full patient treatment course using the MRIdian A3i system.
June 2, 2022
2019 09 17 17 11 0207 Viewray Astro 2019
Accuray to integrate Limbus' AI software
By AuntMinnie.com staff writers
Radiation therapy developer Accuray has inked a deal with artificial intelligence (AI) software developer Limbus to integrate the company's autocontouring algorithms in its Radixact and CyberKnife systems.
June 1, 2022
2019 09 17 16 01 9179 Accuray Astro 2019
ASTRO sees opportunity in CMS delay of RO Model
By AuntMinnie.com staff writers
The American Society for Radiation Oncology (ASTRO) has submitted comments to the U.S. Centers for Medicare and Medicaid Services (CMS) in response to the agency's move to indefinitely postpone the start of an alternative payment model for radiation oncology (the RO Model).
June 1, 2022
2019 09 16 03 57 7061 Astro 2019 400
Out with supine, in with prone for breast radiotherapy
By Amerigo Allegretto
Women with large breasts who are undergoing radiotherapy for breast cancer should be treated while lying on their stomachs rather than on their backs, suggests Canadian research published May 26 in JAMA Oncology.
May 25, 2022
2019 01 19 00 20 7950 Radiotherapy Breast Cancer 400
Previous Page
Page 32 of 466
Next Page